|Bid||10.22 x 3100|
|Ask||10.22 x 21500|
|Day's Range||10.19 - 10.53|
|52 Week Range||5.25 - 67.00|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 08, 2021 - Nov 12, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||14.25|
Subscribe to Yahoo Finance Plus to view Fair Value for TLRYLearn more
Canadian pot producer Tilray in August said it had invested in U.S. cannabis retailer MedMen. Should you buy TLRY stock now?
Canadian marijuana stocks have fallen from their February highs. But one player in the industry got a lot bigger after a merger deal.
Another acquisition agreement shows Canadian companies are positioning for a future legal U.S. market.